GlassScriptPhysician profile
Vipul Shelat
NPI 1699736173
$680.01
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $47.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $128.85 | 2019 | |
| Emd Serono, INC. | $89.26 | 2019 | |
| Biogen, INC. | $78.81 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $67.93 | 2019 | |
| Neurocrine Biosciences, INC. | $46.18 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $36.50 | 2019 | |
| Avanir Pharmaceuticals, INC. | $32.37 | 2019 | |
| Acorda Therapeutics, INC | $32.08 | 2019 | |
| Assertio Therapeutics, INC. | $21.62 | 2019 | |
| Boston Scientific Corporation | $21.49 | 2019 | |
| Lundbeck LLC | $20.00 | 2019 | |
| Ucb, INC. | $16.37 | 2019 | |
| Amgen INC. | $16.16 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.46 | 2019 | |
| Csl Behring | $14.67 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $14.31 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.14 | 2019 | |
| Vanda Pharmaceuticals INC. | $13.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipul Shelat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.